PhRMA Foundation/LinkedIn
May 10, 2026, 09:43
New Research Targets Immune Pathways Behind Blood Clots in APS – PhRMA Foundation
PhRMA Foundation shared a post on LinkedIn:
“In antiphospholipid syndrome (APS), harmful antibodies trigger blood clots and inflammation – sometimes even when patients are on blood thinners. PhF26 awardee Thalia Newman of the University of Michigan is targeting the immune pathways behind this process to reduce risk of blood clots in APS.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 24, 2026, 14:30Highlights From the ASRM/CFAS Business of Medicine Conference 2026 – ASRM
-
Jun 24, 2026, 14:26Smit Bharat Solanki: The Most Important Part of a Myomectomy Happens Before Surgery
-
Jun 24, 2026, 13:56Mario Lumbreras Marquez: Maternal and Perinatal Outcomes in Pregnancy with High PAH Risk
-
Jun 24, 2026, 13:54Creating Psychologically Safe Teams in High-Pressure Healthcare – RCOG
-
Jun 24, 2026, 13:36Marco Zaccaria: The Countdown to GCH2027 Begins Now!
-
Jun 24, 2026, 13:34Surgical Approach to Reduce the Risks of Intraoperative Complications and Postpartum Hemorrhage – IJGO
-
Jun 24, 2026, 13:10How One Follicle Can Vanish or Produce an Aged Egg During IVF? – Fertility Plus
-
Jun 24, 2026, 12:41ACSC2026 Day Two Focuses on Women’s Rights and Respectful Maternity Care – SOGC
-
Jun 24, 2026, 08:13Ongoing Gaps in Contraceptive Access and Experience – BPAS